Author:
Bao Feifei,Liu Mengjie,Gai Wenhua,Hua Yuwei,Li Jing,Han Chao,Zai Ziyu,Li Jiahuang,Hua Zichun
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86(3): 353–364
2. Jazowiecka-Rakus J, Szala S. Antitumour activity of Salmonella typhimurium VNP20047 in B16(F10) murine melanoma model. Acta Biochim Pol 2004; 51(3): 851–856
3. Low KB, Ittensohn M, Luo X, Zheng LM, King I, Pawelek JM, Bermudes D. Construction of VNP20009: a novel, genetically stable antibiotic-sensitive strain of tumor-targeting Salmonella for parenteral administration in humans. Methods Mol Med 2004; 90: 47–60
4. Zheng JH, Min JJ. Targeted cancer therapy using engineered Salmonella typhimurium. Chonnam Med J 2016; 52(3): 173–184
5. Kimura H, Zhang L, Zhao M, Hayashi K, Tsuchiya H, Tomita K, Bouvet M, Wessels J, Hoffman RM. Targeted therapy of spinal cord glioma with a genetically modified Salmonella typhimurium. Cell Prolif 2010; 43(1): 41–48